Gempharmatech
Nanjing, Jiangsu, China
Dr. Liang Juan obtained her Ph.D. in Biomedical Sciences from The Chinese University of Hong Kong. After graduating, she undertook postdoctoral research at Queen's University Belfast and later served as an Associate Researcher at Nanjing University. In 2020, she joined Gempharmatech and she is Currently the director of Research and Development Center, having previously held positions such as Principal Investigator in the autoimmune disease research pipeline.
Dr. Liang has extensive experience in the development of transgenic and disease mice models. Her primary research focus lies in the development of preclinical animal models for induced and spontaneous autoimmune diseases, as well as the establishment of related efficacy testing systems. These efforts are crucial for advancing the development of new treatments and drugs for autoimmune diseases.
0109: Application of Psoriatic Arthritis Mouse Models in Preclinical Pharmacodynamic Evaluation
Sunday, October 26, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
Monday, October 27, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
Monday, October 27, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
Tuesday, October 28, 2025
10:45 AM - 11:00 AM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
